In this instalment, we find out about the life, loves and career drivers of the new director of Regulatory Affairs and QP Services at Wasdell, Colin Newbould.
New data, released by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence, has revealed that the venture capital funding and secondary offerings in the biotech sector are on track to beat last year’s figures
Neil Pullman, principal architect at, Boulting Environmental Services, explores the differences between BIM Levels, their benefits and what it means for the pharmaceutical sector.
In this next instalment of our ‘Meet the maker’ series, we talk with Wendy Dwyer who was recently appointed as chief business officer of Portal Instruments — a Series B funded, clinical stage medical device company focused on advanced drug delivery.
Indivior, a speciality pharmaceutical company, has opened a $30 million research and development (R&D) centre in Hull, UK, to further advance its treatment innovation into the global addiction crisis.
Here, we talk work, life and pharma with Alessandra Rispoli who has been appointed to serve as senior director, Operations for West Pharmaceutical Services’ manufacturing site in Eschweiler, Germany.
Contract development and manufacturing organisation (CDMO) that specialises in spray drying and capsule filling services, Micro-Sphere, is investing €19 million to expand its GMP manufacturing capabilities at its Swiss facility.
In the third episode of our series, we talk to Richard Limb who is the new head of Quality Assurance at one of the UK’s independent suppliers of both Specials and clinical trial medicines to healthcare professionals, Nova Laboratories.
In this article, Ben van der Schaaf, principal at Arthur D. Little, gives a five-step guide to explore possible funding partnerships for lower-priority drug trials — a new model for big pharma.
GlaxoSmithKline (GSK) has made several announcements regarding its forthcoming plans to improve the efficiency and competitiveness of its manufacturing network.
